Citation Impact
Citing Papers
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
2016
Persistent organic pollutants in adipose tissue should be considered in obesity research
2016
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Prevalencia e incidencia de la enfermedad de Alzheimer en Europa: metaanálisis
2016 Standout
Microbiota in health and diseases
2022 Standout
Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide
2003
APOE-Sensitive Cholinergic Sprouting Compensates for Hippocampal Dysfunctions Due to Reduced Entorhinal Input
2016
Acromegaly
2006 Standout
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
2016
Cardiac Effect of Thyrotoxicosis in Acromegaly1
2000
Gastrointestinal Microbiota and Their Contribution to Healthy Aging
2016
Pharmacotherapy or Surgery as Primary Treatment for Acromegaly?
2000
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
2014
Cardiovascular involvement in patients affected by acromegaly: An appraisal
2012
Geographical variation in dementia: systematic review with meta-analysis
2012
Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study
2009
Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients
2001
Is the Acromegalic Cardiomyopathy Reversible? Effect of 5-Year Normalization of Growth Hormone and Insulin-Like Growth Factor I Levels on Cardiac Performance*
2001
Practice guideline update summary: Mild cognitive impairment [RETIRED]
2017 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Preoperative Anxiety and Depression Correlate With Dissatisfaction After Total Knee Arthroplasty: A Prospective Longitudinal Cohort Study of 186 Patients, With 4-Year Follow-Up
2016
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
Medical consequences of acromegaly: What are the effects of biochemical control?
2007
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Comparison of Imaging Biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging
2012
Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study
2002
Increased arterial intima‐media thickness by B‐M mode echodoppler ultrasonography in acromegaly
2001
Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis
2014 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Data Mining Algorithms and Techniques in Mental Health: A Systematic Review
2018 Standout
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly
2002
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
2018
Clinical, quality of life, and economic value of acromegaly disease control
2011
Measures of preoperative anxiety
2019 Standout
Role of the gut microbiota in nutrition and health
2018 Standout
Influence of diet on the gut microbiome and implications for human health
2017 Standout
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool
2010
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
How can elderly apolipoprotein E ε4 carriers remain free from dementia?
2012
Drosophila Histone Demethylase KDM5 Regulates Social Behavior through Immune Control and Gut Microbiota Maintenance
2019
Acromegaly and the Cardiovascular System
2006
Evidence-Based Cognitive Rehabilitation: Updated Review of the Literature From 2003 Through 2008
2011
The long‐term efficacy of conventional radiotherapy in patients with GH‐secreting pituitary adenomas
2005
Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
2016
Gut microbiota changes in the extreme decades of human life: a focus on centenarians
2017
Phenotypes of prediabetes and stratification of cardiometabolic risk
2016
Growth hormone and the heart
2001
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
The 2013 SFRBM discovery award: Selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment
2014
The projected effect of risk factor reduction on Alzheimer's disease prevalence
2011 Standout
Systemic Hypertension and Impaired Glucose Tolerance Are Independently Correlated to the Severity of the Acromegalic Cardiomyopathy1
2000
Mild cognitive impairment as a diagnostic entity
2004 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Frequency of Anxiety after Stroke: A Systematic Review and Meta-Analysis of Observational Studies
2012
A Prediction Model for Mild Cognitive Impairment Using Random Forests
2015
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
2018 Standout
Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
2017
Measures of anxiety: State‐Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale‐Anxiety (HADS‐A)
2011 Standout
Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer’s Disease Subjects
2019
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease
2018
Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study–Cognition Study
2012
Body Mass Index and Decline in Cognitive Function in Older Black and White Persons
2017
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Understanding the impact of sex and gender in Alzheimer's disease: A call to action
2018
Mediterranean diet and inflammaging within the hormesis paradigm
2017
Pesquisa Nacional de Saúde no Brasil: concepção e metodologia de aplicação
2014 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Mild cognitive impairment: Disparity of incidence and prevalence estimates
2012
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Validity of Proxies and Correction for Proxy Use When Evaluating Social Determinants of Health in Stroke Patients
2010
Cardiovascular Effects of Depot Long-Acting Somatostatin Analog Sandostatin LAR in Acromegaly*
2000
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Lanreotide 60 mg, a New Long-Acting Formulation: Effectiveness in the Chronic Treatment of Acromegaly
2003
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Acromegaly: historical perspectives and current therapy
2001
Religion, Spirituality, and Health: The Research and Clinical Implications
2012 Standout
Treatment with Growth Hormone Receptor Antagonist in Acromegaly: Effect on Cardiac Structure and Performance
2006
Are subjective cognitive complaints relevant in preclinical Alzheimer's disease? A review and guidelines for healthcare professionals
2012
Mild Cognitive Impairment
2016
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
Mediterranean Diet and Health: Food Effects on Gut Microbiota and Disease Control
2014
High Prevalence of Cardiac Valve Disease in Acromegaly: An Observational, Analytical, Case-Control Study
2003
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
2012
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
2016 Standout
Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis
2007
Works of Barbara Caracciolo being referenced
Cognitive decline, dietary factors and gut–brain interactions
2013
Cardiac Effects of Slow-Release Lanreotide, a Slow-Release Somatostatin Analog, in Acromegalic Patients1
1999
Self-perceived distress and self-perceived functional recovery after recent total hip and knee arthroplasty
2005
Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer’s Disease
2016
Body Mass Index Predicts Progression of Mild Cognitive Impairment to Dementia
2016
Rehabilitation of attention in two patients with traumatic brain injury by means of ‘attention process training’
2006
Epidemiological studies of cognitive impairment and dementia across Eastern and Middle European countries (epidemiology of dementia in Eastern and Middle European Countries)
2010
Differential Distribution of Subjective and Objective Cognitive Impairment in the Population: A Nation-Wide Twin-Study
2012
Can Faith Protect From Emotional Distress After Stroke?
2007
Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
2010
Occurrence of cognitive impairment and dementia in the community
2008
Mild cognitive impairment: a concept in evolution
2014
Accelerated Progression from Mild Cognitive Impairment to Dementia Among APOE ε4ε4 Carriers
2012